Close Menu
TechCentralTechCentral

    Subscribe to the newsletter

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    Facebook X (Twitter) YouTube LinkedIn
    WhatsApp Facebook X (Twitter) LinkedIn YouTube
    TechCentralTechCentral
    • News

      TechCentral Nexus S0E3: Behind Takealot’s revenue surge

      23 June 2025

      Letter: South Africa risks missing AI wave while world surges ahead

      23 June 2025

      Prosus profit surges 47% as e-commerce bet pays off

      23 June 2025

      Apple shifts its AI strategy

      23 June 2025

      Takealot rides subscription wave to revenue surge

      23 June 2025
    • World

      Watch | Starship rocket explodes in setback to Musk’s Mars mission

      19 June 2025

      Trump Mobile dials into politics, profit and patriarchy

      17 June 2025

      Samsung plots health data hub to link users and doctors in real time

      17 June 2025

      Beijing’s chip champions blacklisted by Taiwan

      16 June 2025

      China is behind in AI chips – but for how much longer?

      13 June 2025
    • In-depth

      Meta bets $72-billion on AI – and investors love it

      17 June 2025

      MultiChoice may unbundle SuperSport from DStv

      12 June 2025

      Grok promised bias-free chat. Then came the edits

      2 June 2025

      Digital fortress: We go inside JB5, Teraco’s giant new AI-ready data centre

      30 May 2025

      Sam Altman and Jony Ive’s big bet to out-Apple Apple

      22 May 2025
    • TCS

      TCS+ | AfriGIS’s Helen Hulett on how tech can help resolve South Africa’s water crisis

      18 June 2025

      TechCentral Nexus S0E2: South Africa’s digital battlefield

      16 June 2025

      TechCentral Nexus S0E1: Starlink, BEE and a new leader at Vodacom

      8 June 2025

      TCS+ | The future of mobile money, with MTN’s Kagiso Mothibi

      6 June 2025

      TCS+ | AI is more than hype: Workday execs unpack real human impact

      4 June 2025
    • Opinion

      South Africa pioneered drone laws a decade ago – now it must catch up

      17 June 2025

      AI and the future of ICT distribution

      16 June 2025

      Singapore soared – why can’t we? Lessons South Africa refuses to learn

      13 June 2025

      Beyond the box: why IT distribution depends on real partnerships

      2 June 2025

      South Africa’s next crisis? Being offline in an AI-driven world

      2 June 2025
    • Company Hubs
      • Africa Data Centres
      • AfriGIS
      • Altron Digital Business
      • Altron Document Solutions
      • Altron Group
      • Arctic Wolf
      • AvertITD
      • Braintree
      • CallMiner
      • CambriLearn
      • CYBER1 Solutions
      • Digicloud Africa
      • Digimune
      • Domains.co.za
      • ESET
      • Euphoria Telecom
      • Incredible Business
      • iONLINE
      • Iris Network Systems
      • LSD Open
      • NEC XON
      • Network Platforms
      • Next DLP
      • Ovations
      • Paracon
      • Paratus
      • Q-KON
      • SevenC
      • SkyWire
      • Solid8 Technologies
      • Telit Cinterion
      • Tenable
      • Vertiv
      • Videri Digital
      • Wipro
      • Workday
    • Sections
      • AI and machine learning
      • Banking
      • Broadcasting and Media
      • Cloud services
      • Contact centres and CX
      • Cryptocurrencies
      • Education and skills
      • Electronics and hardware
      • Energy and sustainability
      • Enterprise software
      • Fintech
      • Information security
      • Internet and connectivity
      • Internet of Things
      • Investment
      • IT services
      • Lifestyle
      • Motoring
      • Public sector
      • Retail and e-commerce
      • Science
      • SMEs and start-ups
      • Social media
      • Talent and leadership
      • Telecoms
    • Events
    • Advertise
    TechCentralTechCentral
    Home » News » Echoes of neurodegenerative disease in fatal Covid cases

    Echoes of neurodegenerative disease in fatal Covid cases

    By Agency Staff22 June 2021
    Twitter LinkedIn Facebook WhatsApp Email Telegram Copy Link
    News Alerts
    WhatsApp

    The following is a round-up of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus.

    Covid-19 brains show inflammation, ‘circuitry’ problems

    The brain inflammation and impaired “brain circuitry” seen in people who die of Covid-19 look a lot like what doctors see in the brains of people who die of neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease, researchers reported on Monday in the journal Nature.

    Analyses of brain tissue from eight people who died from Covid-19 and 14 others who died from other causes showed “striking changes” in the Covid-19 patients’ brains, Stanford University researcher Tony Wyss-Coray said in an interview.

    His team at Stanford, with colleagues at the University of Saarbruecken in Germany, analysed thousands of genes in each of 65 309 individual cells taken from the brain-tissue samples. Genes involved with cognition, schizophrenia and depression were more often “turned on” in the Covid-19 patients’ brains, they found.

    The findings may help explain the brain fog, fatigue and other neurological and psychiatric symptoms of long Covid

    “There also were signs of distress in neurons in the cerebral cortex, the brain region that plays a key role in decision-making, memory and mathematical reasoning,” the researchers said in a statement. “These neurons … form complex logic circuits that perform those higher brain functions.”

    Wyss-Coray said his team could not find the virus itself in the brain, which suggests that “virus infection in the rest of the body could be enough to cause neurological symptoms, even in people who do not die from the disease.”

    The findings, Wyss-Coray noted in a statement, “may help explain the brain fog, fatigue and other neurological and psychiatric symptoms of long Covid”.

    Poor sleep history linked with more severe Covid-19

    Poor sleep habits may be linked with higher risk for severe illness in patients with Covid-19, according to Harvard University researchers.

    They analysed survey responses from more than 46 000 participants in the long-term UK Biobank study, including 8 422 who tested positive for Covid-19.

    Participants had answered questions from 2006 to 2010 about sleep duration, daytime sleepiness, insomnia and body clocks. For the new study, based on their responses, the researchers assigned scores ranging from 0 to 6, with higher scores indicating multiple poor sleep “traits”.

    In participants with Covid-19, poor scores were associated with higher odds of death. This was true even after researchers accounted for issues known to be risk factors for poor Covid-19 outcomes such as sleep apnea, obesity and smoking, they reported on Friday in the journal Clinical Infectious Diseases.

    Even people with two occasional or one frequent poor sleep trait appeared to experience higher risks for hospitalisation and death, although the difference was not statistically significant and more study is needed to confirm the finding, the researchers said.

    Poor sleep affects the immune system and blood clotting, both of which are key to the body’s fight against Covid-19, and “tracking sleep behaviour may have importance in identifying those at increased risk for Covid-19 mortality and hospitalisation,” the authors said.

    Most Covid-19 antibody drugs likely work against variants

    Most Covid-19 antibody drugs that are approved for emergency use in the US — and some that are still in development — are likely to protect against variants of the novel coronavirus, new data suggests.

    In test tube experiments, and in mice and hamsters, researchers exposed the antibodies, alone and in combinations, to “engineered” versions of mutated virus and to actual virus obtained from patients infected with Alpha, Beta or Gamma variants — first identified in Britain, South Africa and Brazil, respectively — or variants first seen in New York, California or India.

    Some individual drugs appeared to lose effectiveness against the variants in test tubes — but in the animals, low doses of most of the drugs, given in combinations, were protective, the researchers reported on Monday in the journal Nature.

    Another advantage of the combinations is that they “seemed to prevent the emergence of resistant viruses”, study co-author Jacco Boon of Washington University School of Medicine in St Louis said in the statement. “Resistance arose with some of the monotherapies, but never with combination therapy.”  — Reported by Nancy Lapid, (c) 2021 Reuters



    top
    Subscribe to TechCentral Subscribe to TechCentral
    Share. Facebook Twitter LinkedIn WhatsApp Telegram Email Copy Link
    Previous ArticleWhy China is cracking down on cryptocurrencies
    Next Article Why even with vaccines, Covid will always be with us

    Related Posts

    18GW in unplanned breakdowns cripple Eskom

    2 November 2021

    Nersa kicks the Karpowership can down the road

    13 September 2021

    If you think South African load shedding is bad, try Zimbabwe’s

    13 September 2021
    Company News

    IoT connectivity management in South Africa – expert insights

    23 June 2025

    Let’s reimagine Joburg using the power of tech, data and AI

    23 June 2025

    Netstar doubles down on global markets while backing SA growth

    23 June 2025
    Opinion

    South Africa pioneered drone laws a decade ago – now it must catch up

    17 June 2025

    AI and the future of ICT distribution

    16 June 2025

    Singapore soared – why can’t we? Lessons South Africa refuses to learn

    13 June 2025

    Subscribe to Updates

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    © 2009 - 2025 NewsCentral Media

    Type above and press Enter to search. Press Esc to cancel.